2. Stover C, Pham X, Erwin A, Miizoguchi S, Warrener P, Hickey M, y col.Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 2000; 406: 959-964.

3. Nikaido H. Multiple antibiotic resistance and efflux. Curr Opin Microbiol 1998;1:516-523.

4. Arnello M, Quintana J, Barraza P. Neutropenia febril en niños con cáncer en un centro asistencial en Santiago, Chile. Rev Chil Infect 2007; 24:27-32.

5. Dale R, Schnell G, Wong J. Therapeutic efficacy of ?nubiotics ? against burn wound infection by Pseudomonas aeruginosa. Antimicrob agents chemother 2004;48:2918-2923.

6. Lyczak J, Cannon C, Pier G. Lung infections associated with cystic fibrosis. Clin Microbiol Rev 2002;15:194-222.

7. Ethel S, Sini V, Jolly J. Gentamycin resistance in biofilm producing Pseudomonas aeruginosa associated urinary tract infections. Indian J of Medical Sciences 2005; 59:214-216.

8. Sanz P, Ramos A, Asensio A, García M, Linares M. Mortalidad y factores pronósticos en pacientes hospitalizados por bacteremia adquirida en la comunidad. An Med Interna 2006;23: 62-65

9. Davidson S, Yellin E, Shoked I, Rubistein E. Pseudomonas aeruginosa meningitis with an azlocillin combination. Infection 2005; 10: S168-S169.

10. Andriesse I, Verhoef J. Nosocomial pneumonia: rationalizing the approach to empirical therapy. Treat Respir Med 2006; 5(1):11-30.

11. Sato H, Okinaga K, Saito H. Role of pili in the pathogenesis of Pseudomonas aeruginosa burn infection. Microbiol Immunol 1998; 32:131-139.

12. Vitkauskiene A, Scheuss S, Sahly H, Sakalauskas R, Dudzevicius V. Pseudomonas aeruginosa strains from nosocomial pneumonia are more serum resistant than P. aeruginosa strains from noninfectious respiratory colonization processes. Infection 2005; 33(5-6):356-361.

13. Shaver M, Hauser R. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung. Infect Immun 2004; 72:6969-6977.

14. Guadarrama S, Pulcini E, Broadaway C, Pyle H. Pseudomonas aeruginosa growth and production of Exotoxin A in static and modeled microgravity environments. Gravit Space Biol Bull 2005; 18:85-86.

15. Takumida M, Anniko M. Protective effect of edaravone against the ototoxicity of Pseudomonas aeruginosa exotoxin A. Acta Otolaryngol 2006; 126(1):15-19.

16. Woods D, Sokol P. Use of tramposon mutants to assess the role of exoenzyme S in chronic pulmonary disease due to Pseudomonas aeruginosa. Eur J Clin Microbiol 1985; 4:163-169.

17. Zhang Y, Barbieri T. A leucine-rich motif targets Pseudomonas aeruginosa ExoS within mammalian cells. Infect Immun 2005; 73:7938-7945.

18. Ciragil P, Soyletir G. Alginate, elastase and alkaline protease production of Pseudomonas aeruginosa strains isolated from various body sites. Mikrobiyol Bul 2004; 38:341-347.

19. Khan S, Misra A, Tripathi C, Mishra B, Bihari V. Response surface optimization of effective medium constituents for the production of alkaline protease from a newly isolated strain of Pseudomonas aeruginosa. Indian J Exp Biol 2006; 44:151-156.

20. Karadzic I, Masui A, Fujiwara N. Purification and characterization of a protease from Pseudomonas aeruginosa grown in cutting oil. J Biosci Bioeng 2004; 98(3):145-152.

21. Horvat R, Clabaugh M, Dubal-Jobe C, Parmely M. Inactivation of human gamma interferon by Pseudomonas aeruginosa proteases: elastase augments the effects of alkaline protease despite the presence of alpha 2-macroglobulin. Infect Immun 1989;57: 1668-1674.

22. Kohler W, Zentralblatt fur. Bakteriologie-100 years ago: evidence for a haemolysin produced by Pseudomonas aeruginosa. Int J Med Microbiol 2000; 290(3):205-206.

23. Barker A, Vasil A, Filloux A, Ball G, Wilderman P, Vasil M. A novel extracellular phospholipase C of Pseudomonas aeruginosa is required for phospholipid chemotaxis. Mol Microbiol 2004; 53(4):1089-1098.

24. Toshiyuki Y, Yoichi H, Coichi I, Yoshitsugu M, Shigefumi M, Kazunori T y col. Prolonged survival of mice with Pseudomonas aeruginosa induced sepsis by rlL-12 modulation of IL-10 and interferon [gamma]. J Clin Microbiol 2000; 49:701-707

25. Denning G. Wollenweber L, Railsback M, Cox Ch, Stoll L, Britigan B. Pseudomonas pyocyanin increases interleukin-8 expression by human airway epithelial cells. Infect Immun 1998; 66:5777-5784

26. Gambello M, Iglewski B. Cloning and characterization of the Pseudomonas aeruginosa lasR gene, a transcripcional activator of elastase expression. J Bacteriol 1991;179:3000-3009.

27. Pearson J. Structure of the autoinducer required for expression of Pseudomonas aeruginosa virulence genes. Proc Natl Acad Sci U.S.A. 1994;91:197-201

28. Brint, J. M. & D. E. Ohman. Synthesis of multiple exoproducts in

Pseudomonas aeruginosa is under control of RhlR-RhlI, another set of regulators in strain PAO1 with homology to the autoinducer-responsive LuxR-LuxI family. J Bacteriol 1995 ;177: 7155-7163.

29. Pearson J, Passador L, Iglewski B, Greenberg E. A second N-acylhomoserine lactone signal produced by Pseudomonas aeruginosa. Proc Natl Acad Sci U.S.A 1995;92:1490-1494.

30. Chugani S., Whiteley M, Lee K, D?Argenio D, Manoil C, Greenberg P. QscR a modulator of quorum- sensing signal synthesis and virulence in Pseudomonas aeruginosa. Proc Natl Acad Sci U.S.A 2001; 98:2752-2757

31. Polanco N, Moronta R, O?Daly J. Variabilidad en los exoproductos de Pseudomonas aeruginosa aisladas de diferentes muestras clínicas. VITAE Academia Biomédica Digital 2006; Nº 27

32. Briceño E, Suárez E, Michelangi C, Feliciangeli D, Ptaiza E. Mendible J, Villalón M, Aguilera M, Ceballo H. Godoy J, y col. Código de Bioética y Bioseguridad 2002. Capítulo 2 y 3. Ministerio de Ciencia y Tecnología (FONACIT). 2da Edición. Venezuela

33. Laemmli U. Clivage of structural proteins during the assembly for the head of bacteriophage T4. Nature 1970;227:680-685.

34. Holloway B, Morgan A. Genome organization in Pseudomonas. Ann Rev Microbiol 1986; 40:79-105.

35. Hourianopoulou M, Lambropoulos S, Papafragas E, Falagas M. Effect of aerosolized colistin on multidrug-resistant Pseudomonas aeruginosa in bronchial secretions of patients without cystic fibrosis J. Chemother 2005;17:536-538.

36. Kadota J. Interaction between host immune response and Pseudomonas infection in chronic airway inflammatory disease. J Japanese Respiratory Society 2005;43:80-84

37. Smith R, Iglewski B. Pseudomonas aeruginosa quorum-sensing systems and virulence. Curr Opin Microbiol 2003;6:56-60

38. Dubin P, Kolls J. Pseudomonas aeruginosa and the host pulmonary immune response. Expert Review of Respiratory Medicine 2007; 1:121-137.

39. Wagner V, Frelinger J. Barth R Iglewski B. Quorung sensing: dynamic response of Pseudomonas aeruginosa to external signal. Trends Microbiol 2006; 14:55-58

40. Khan S, Misra A, Tripathi C, Mishra B, Bihari V. Response surface optimization of effective medium constituents for the production of alkaline protease from a newly isolated strain of Pseudomonas aeruginosa. Indian J Exp Biol 2006; 44:151-156.

41. Rudner X, Zheng Z, Berk R, Irwin R, Haslett L. Corneal epithelial glycoproteins exhibit Pseudomonas aeruginosa pilus binding activity. Invest Ophtalmol Vis sci 1992; 33:2181-2193.

42. Hartl D, Griese M. Surfactant protein D in human lung diseases. European J Clin Invest 2006; 36:423-435.

43. Sadikot R, Blackwell T, Christman J, Prince A. Pathogen-Host interactions in Pseudomonas aeruginosa pneumonia. Am J Respiratory and Critical Care Medicine 2005; 171: 1209-1223